InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Mirabelli Christopher. Insider active across 2 companies, notably Leap Therapeutics, INC.. In total, 7 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €745k. History available since 13 November 2024. The latest transaction was filed on 26 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Mirabelli Christopher is a declared insider, a director of CYPHERPUNK TECHNOLOGIES INC. and Chairman of the Board of Leap Therapeutics, INC. He has 7 filings in total, and across the 7 sampled filings between 2024-01-30 and 2026-03-30, sales total 744710 EUR and the most frequent transaction nature is option exercise.